Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 20, 2021

SELL
$4.24 - $5.51 $304,788 - $396,080
-71,884 Closed
0 $0
Q4 2020

Jan 22, 2021

BUY
$2.53 - $4.71 $4,766 - $8,873
1,884 Added 2.69%
71,884 $300,000
Q4 2019

Jan 21, 2020

SELL
$2.56 - $3.08 $501,736 - $603,652
-195,991 Reduced 73.68%
70,000 $0
Q2 2019

Aug 01, 2019

BUY
$3.54 - $4.64 $169,212 - $221,791
47,800 Added 21.91%
265,991 $1.03 Million
Q1 2019

May 02, 2019

BUY
$3.32 - $5.28 $449,322 - $714,584
135,338 Added 163.35%
218,191 $1.04 Million
Q4 2018

Feb 14, 2019

BUY
$3.31 - $5.24 $42,543 - $67,349
12,853 Added 18.36%
82,853 $283,000
Q1 2018

May 09, 2018

BUY
$4.5 - $5.9 $315,000 - $413,000
70,000 New
70,000 $350,000

Others Institutions Holding ARAY

About ACCURAY INC


  • Ticker ARAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 93,579,696
  • Market Cap $163M
  • Description
  • Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
More about ARAY
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.